Relationship between serum vascular cell adhesion molecule-1 and endothelin-1 levels with organ involvement and disease activity in systemic lupus erythematosus patients

被引:9
作者
Hajialilo, M. [1 ]
Tayari, P. [1 ]
Ghorbanihaghjo, A. [2 ]
Khabbazi, A. [1 ]
Mahdavi, A. Malek [1 ]
Rashtchizadeh, N. [1 ]
机构
[1] Tabriz Univ Med Sci, Connect Tissue Dis Res Ctr, Golgasht St,POB 5166614754, Tabriz, Iran
[2] Tabriz Univ Med Sci, Biotechnol Res Ctr, Tabriz, Iran
关键词
Systemic lupus erythematosus; vascular cell adhesion molecule-1; endothelin-1; PLASMA-CONCENTRATIONS; SOLUBLE VCAM-1; CLINICAL-SIGNIFICANCE; RHEUMATOID-ARTHRITIS; SCLERODERMA PATIENTS; ACTIVATION MARKERS; LEUKOCYTE ADHESION; E-SELECTIN; EXPRESSION; ANTIBODIES;
D O I
10.1177/0961203318796285
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Endothelial dysfunction plays an important role in pathogenesis of systemic lupus erythematosus (SLE). Considering the importance of serum soluble vascular cell adhesion molecule-1 as the most abundant of the circulating adhesion molecules increased as a result of endothelial dysfunction and the role of endothelin-1 in pathophysiology of SLE, this study aimed to evaluate serum soluble vascular cell adhesion molecule-1 and endothelin-1 levels in SLE patients compared to healthy subjects. Methods In this cross-sectional study, 60 SLE patients according to the Systemic Lupus International Collaborating Clinics classification criteria for SLE and 40 age and sex-matched healthy controls were included. In patients, clinical examination was performed and SLE disease activity index was assessed. Serum endothelin-1 and soluble vascular cell adhesion molecule-1 levels were measured using ELISA kits. Results The meanstandard deviation age of patients and controls was 31.91 +/- 7.66 and 33.20 +/- 10.08 years, respectively. Compared to healthy controls, serum soluble vascular cell adhesion molecule-1 (1023.8 +/- 352.96 vs. 866.06 +/- 109.91) and endothelin-1 (77.83 +/- 16.27 vs. 54.45 +/- 12.01) was significantly higher in SLE patients (P=0.003 and P<0.001, respectively). The most common organs involved in patients were skin, joint and kidney. There were no significant differences in serum soluble vascular cell adhesion molecule-1 and endothelin-1 levels according to organ involvement, activity of disease and the conventional serum markers of disease activity (P>0.05). There was no significant correlation between disease activity, organ involvement and negative or positivity of autoantibodies as well as serum complement with endothelin-1 and vascular cell adhesion molecule-1 levels (P>0.05). Conclusions Although our study revealed higher serum soluble vascular cell adhesion molecule-1 and endothelin-1 levels in SLE patients compared to healthy controls, there were no significant correlations between their serum levels with organ involvement and disease activity.
引用
收藏
页码:1918 / 1925
页数:8
相关论文
共 65 条
[1]   Assessment and treatment of endothelial dysfunction in humans [J].
Anderson, TJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :631-638
[2]   Premature coronary-artery atherosclerosis in systemic lupus erythematosus [J].
Asanuma, Y ;
Oeser, A ;
Shintani, AK ;
Turner, E ;
Olsen, N ;
Fazio, S ;
Linton, MF ;
Raggi, P ;
Stein, CM .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (25) :2407-2415
[3]   Clinical correlations of potential activity markers in systemic sclerosis [J].
Becvár, R ;
Stork, J ;
Pesáková, V ;
Stánová, A ;
Hulejová, H ;
Rysová, L ;
Zatloukalová, A ;
Zatloukal, P ;
Jáchymová, M ;
Pourová, AL .
AUTOIMMUNE DISEASES AND TREATMENT: ORGAN-SPECIFIC AND SYSTEMIC DISORDERS, 2005, 1051 :404-412
[4]   Antiendothelial cell antibodies in vasculitis and connective tissue disease [J].
Belizna, C. ;
Duijvestijn, A. ;
Hamidou, M. ;
Tervaert, J. W. Cohen .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) :1545-1550
[5]  
Bertsias G, 2012, EULAR, P476
[6]   ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE-1 - AN INDUCIBLE RECEPTOR FOR NEUTROPHILS RELATED TO COMPLEMENT REGULATORY PROTEINS AND LECTINS [J].
BEVILACQUA, MP ;
STENGELIN, S ;
GIMBRONE, MA ;
SEED, B .
SCIENCE, 1989, 243 (4895) :1160-1165
[7]   Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities [J].
Bhattacharyya, Swati ;
Wei, Jun ;
Varga, John .
NATURE REVIEWS RHEUMATOLOGY, 2012, 8 (01) :42-54
[8]   Functional heterogeneity of anti-endothelial cell antibodies [J].
Bordron, A ;
Révélen, R ;
D'Arbonneau, F ;
Dueymes, M ;
Renaudineau, Y ;
Jamin, C ;
Youinou, P .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 124 (03) :492-501
[9]  
Carvalho D, 1999, ARTHRITIS RHEUM-US, V42, P631, DOI 10.1002/1529-0131(199904)42:4<631::AID-ANR5>3.0.CO
[10]  
2-X